Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
| NAV as of Feb 02, 2026 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹9.1443-0.17% 1 day change | -8.67% | App exclusive | ₹587 Cr |
| Expense ratio | 0.6% as on Feb 02, 2026 |
| Exit load | 1.0% Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.! |
| AUM (Fund size) | ₹587 Cr |
| Lock-in Period | Nil |
| Age | 7 m since Jun 09, 2025 |
| Benchmark | BSE Healthcare TRI |
| Min. investment | SIP: ₹1000 & Lumpsum: ₹5000 |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
| Period | This fund | Category average |
|---|---|---|
| 1 Month | -4.46% | -5.82% |
| 3 Months | -6.84% | -8.12% |
| 6 Months | -7.83% | -7.43% |

Large Cap 35.31%
Mid Cap 29.11%
Small Cap 30.94%
Other Cap 0%
Healthcare 92.06%
Insurance 3.3%
Bifurcation by Credit Quality is not available for this fund
Others 4.49%
CBLO 4.49%
Net Receivables 0.15%
Others 0.15%

| Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | -4.46% | -7.83% | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | -6.69% | -7.27% | 1.31% | 27.18% | 17.12% | 15.04% |
| SBI Healthcare Opportunities Fund | -4.76% | -6.72% | -1.83% | 24.29% | 16.31% | 12.48% |
| DSP Healthcare Fund | -6.4% | -5.7% | -4.45% | 21.15% | 15.3% | 15.13% |
| Tata India Pharma & Healthcare Fund | -6.49% | -6.3% | -1.36% | 22.64% | 15.37% | 12.93% |
| Mirae Asset Healthcare Fund | -5.99% | -6.28% | 0.73% | 22.31% | 15.79% | 15.02% |
| Fund name | Std. deviation | Beta | Sharpe | Sortino |
|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 16.02 | 0.95 | 1.21 | 1.72 |
| SBI Healthcare Opportunities Fund | 14.42 | 0.85 | 1.14 | 1.83 |
| DSP Healthcare Fund | 14.85 | 0.85 | 1.0 | 1.7 |
| Tata India Pharma & Healthcare Fund | 16.37 | 0.98 | 0.95 | 1.48 |
| Mirae Asset Healthcare Fund | 16.5 | 0.98 | 0.93 | 1.49 |
| Fund name | ETM Rank | AUM | Fund age | Expense ratio |
|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | N.A. | 587 Cr | 7 m | 0.6% |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,456 Cr | 7 yrs 7 m | 1.02% |
| SBI Healthcare Opportunities Fund | N.A. | 3,989 Cr | 13 yrs 1 m | 0.92% |
| DSP Healthcare Fund | N.A. | 3,114 Cr | 7 yrs 2 m | 0.66% |
| Tata India Pharma & Healthcare Fund | N.A. | 1,311 Cr | 10 yrs 1 m | 0.71% |
| Mirae Asset Healthcare Fund | N.A. | 2,771 Cr | 7 yrs 7 m | 0.48% |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
| Fund AUM | 587 Cr as on Dec 31, 2025 |
| Scheme document | View Scheme Document |
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
| No. of schemes | 41 view all schemes |
| Total AUM | 53,480 Cr as on Dec 31, 2025 |
| Address | BNP Paribas House, 7th Floor, G-Block, Bandra Kurla Complex, Bandra Mumbai, 400051 |
| Phone | 022-33704000 |
| Fund name | ETM Rank | AUM | 1Y | 5Y |
|---|---|---|---|---|
| Baroda BNP Paribas Midcap Fund | N.A. | 2,313 Cr | 10.02% | 20.79% |
| Baroda BNP Paribas Multi Cap Fund | N.A. | 3,142 Cr | 2.12% | 18.18% |
| Baroda BNP Paribas Large & Mid Cap Fund | N.A. | 1,757 Cr | 6.71% | 18.01% |
| Baroda BNP Paribas ELSS Tax Saver Fund | N.A. | 941 Cr | 8.8% | 14.79% |
| Baroda BNP Paribas India Consumption Fund | N.A. | 1,546 Cr | -4.6% | 14.76% |
| Baroda BNP Paribas Large Cap Fund | N.A. | 2,702 Cr | 7.14% | 14.19% |
The current Net Asset Value (NAV) of the Baroda BNP Paribas Health and Wellness Fund - Direct Growth plan is approximately ₹9.1443 as of Feb 02, 2026.
The Baroda BNP Paribas Health and Wellness Fund - Direct Growth has an expense ratio of 0.6%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The Baroda BNP Paribas Health and Wellness Fund currently has assets under management (AUM) or fund size valued at approximately 587 Cr as on Dec 31, 2025.
The Baroda BNP Paribas Health and Wellness Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 7.17% |
| Mankind Pharma Ltd. | 7.11% |
| Cipla Ltd. | 6.69% |
| Max Healthcare Institute Ltd. | 5.87% |
| Abbott India Ltd. | 4.84% |
| Apollo Hospitals Enterprise Ltd. | 4.8% |
| Aster DM Healthcare Ltd. | 4.73% |
| Lupin Ltd. | 4.49% |
| Divi's Laboratories Ltd. | 4.35% |
| Torrent Pharmaceuticals Ltd. | 4.26% |
The Baroda BNP Paribas Health and Wellness Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 92.06% |
| Insurance | 3.3% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. The whole process takes just a few minutes. Here's how it works:
For the Desktop Version:
For the Mobile Version:
That's it. Your investment in the Baroda BNP Paribas Health and Wellness Fund is complete.
Redeeming your investments in the Baroda BNP Paribas Health and Wellness Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.
